Web-based references relating to the number under the disk sign
1 Br J Psychiatry. 2002 Jan;180:8-12. Williams DD. The case against; No link available; page 312
2 Hesse
[Link]; page 319
3 Salman Rushdie: Midnight's Children
[Link]; page 320
4 George Orwell, Inside the Whale, 1940
[Link]; page 320
5 Oxford Textbook of Psychiatry, 1st ed; Gelder">[Link]; page 320
6 BMJ 1999;318:186-188. Narrative based medicine. Stories we hear and stories we tell: analysing talk in clinical practice. Glyn Elwyn
[Link]; page 321
7 Mishler E, 1984 The Discourse of Medicine: Dialectics of- Medical Interviews, Norwood, NJ, Ablex
[Link]; page 321
8 Psychol Bull. 1998 Jul;124(1):22-53. Rind B. A meta-analytic examination of assumed properties of child sexual abuse using college samples. Medline abstract, 59 trials
[Link]; page 323
9 Polonius -- W Shakespeare; Hamlet, Prince of Denmark
[Link]; page 324
10 Issues of sexual orientation and suicide
[Link]; page 328
11 Lucinda Brayford, Martin Boyd. 1952
[Link]; page 328
12 Parents' problems with gay offspring
[Link]; page 328
13 Pollack and Schwartz in their book, The Journey Out - A guide for and about lesbian, gay, and bisexual teens.
[Link]; page 328
14 Health Commun. 2000;12(2):195-218. Troth A. Factors predicting safe-sex talk and condom use in early sexual relationships.
[Link]; page 328
15 We thank Beth Miller & Justin Williams for formulating this page">[Link]; page 328
16 London addresses: Family Planning: 2 Pentonville Rd, N1 9FP 0207 837 4044; Brook Centre: 165 Grays Inn Rd, WC1X 8UD; 0207 713 9000. Sex Education Forum: 8 Wakley Street, EC1V 7QE; Contraceptive Education Service 0207 837 4044. [phone numbers]; No links available; page 328
17 Age & Ageing The place of the specialist home for the elderly mentally infirm in the care of mentally disturbed old people. AS de Zoysa and G Blessed; No link available; page 329
18 Worthing Churches Homeless Projects
[Link]; page 329
19 Psychiatr Q. 2001 Winter;72(4):291-306. Hellerstein DJ. Integrating services for schizophrenia and substance abuse.
[Link]; page 329
20 Cochrane Database Syst Rev. 2000;(4):CD001088. Ley A. Treatment programmes for people with both severe mental illness and substance misuse.
[Link]; page 329
21 J Urol. 2001 Apr;165(4):1158-61. Bohle A. Burn-out of urologists in the county of Schleswig-Holstein, Germany: a comparison of hospital and private practice urologists.
[Link]; page 333
22 Patient Educ Couns. 2001 Apr;43(1):23-30. Gorter RC. A career counseling program for dentists: effects on burnout. Medline abstract, n=171
[Link]; page 333
23 Behav Res Ther. 2001 Apr;39(4):423-42. Visser S. The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy.
[Link]; page 334
24 Dissociation in people who have near-death experiences: out of their bodies or out of their minds? Author: Greyson B. Journal: Lancet; 2000 Feb 5 ; 355(9202):460-3. PubMed ID: 10841127
[Link]; page 335
25 Depression: management of depression in primary and secondary care
[Link]; page 336
26 Psychiatr Q. 2002 Spring;73(1):71-82. Joseph J. Twin studies in psychiatry and psychology: science or pseudoscience?
[Link]; page 336
27 Neurosci Res. 2000 Oct;38(2):193-8. Kram ML. Effects of learned helplessness on brain GABA receptors.
[Link]; page 336
28 Am J Psychiatry. 2000 Oct;157(10):1552-62. Sullivan PF. Genetic epidemiology of major depression: review and meta-analysis.
[Link]; page 336
29 Cochrane Database Syst Rev. 2000;(2):CD000448. Linde K. St John's wort for depression. Medline abstract, Meta-analysis
[Link]; page 336
30 J Affect Disord. 2001 May;64(2-3):261-5. Bschor T. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.
[Link]; page 336
31 Link no longer available; page 337
32 CG16 Self-harm - NICE guideline
[Link]; page 338
33 Lancet. 2002 Mar 9;359(9309):813-4. Jenkins R. Addressing suicide as a public-health problem.
[Link]; page 338
34 BMJ. 2000 Jan 8;320(7227):75A. Yamey G. Suicide rate is decreasing in england and wales.
[Link]; page 338
35 Suicide: an unnecessary death [book by Professor Danuta Wasserman, Director of the WHO Collaborating Centre for Suicide Prevention in Stockholm]
[Link]; page 338
36 Tokushima J Exp Med. 1994 Dec;41(3-4):115-32. Goto H. Epidemiological studies on regional differences in suicide mortality and its correlation with socioeconomic factors.
[Link]; page 338
37 Lancet. 1999 Apr 24;353(9162):1397-400. Appleby L. Aftercare and clinical characteristics of people with mental illness who commit suicide: a case-control study. Medline abstract, n=149
[Link]; page 338
38 Am J Med. 2000 Jan;108(1):54-64. Mulrow CD. Efficacy of newer medications for treating depression in primary care patients.
[Link]; page 340
39 J Affect Disord. 2000 Nov;60(2):121-30. Coppen A. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. Medline abstract, N=127
[Link]; page 340
40 Br J Psychiatry. 2002 May;180:396-404. Smith D. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Medline abstract, n=5562
[Link]; page 340
41 Am J Psychiatry. 2000 Mar;157(3):351-9. Robinson RG. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
[Link]; page 340
42 Psychother Psychosom. 1998 Jul-Oct;67(4-5):271-4. Benazzi F. Weight gain in depression remitted with antidepressants: pharmacological or recovery effect?
[Link]; page 340
43 Wessely S, Kerwin R. JAMA 2004;292:338-343, 379-381.
[Link]; page 34144?
44 Link no longer available; page 341
45 Elkin I et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989 Nov;46(11):971-82; discussion 983.
[Link]; page 341
46 Conte HR et al. Combined psychotherapy and pharmacotherapy for depression. A systematic analysis of the evidence. Vol. 43 No. 5, May 1986.
[Link]; page 341
47 Paykel ES. Psychotherapy, medication combination and compliance. J Clin Psychiatry. 1995;56(suppl 1):24-30.
[Link]; page 341
48 Loonen AJ. Continuation and maintenance therapy with antidepressive agents: meta-analysis of research. Pharm weekly Sci 1991;13:
[Link]; page 341
49 Geddes JR et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361:653-661
[Link]; page 341
50 Essential Psychpharmacology. Neuroscientific basis and practical applications. Second Edition. Stahl SM. publisher
[Link]; page 341
51 Cochrane Database Syst Rev. 2000;(2):CD000448. Linde K. St John's wort for depression.
[Link]; page 341
52 Arch Gen Psychiatry. 2000 May;57(5):425-34. Sackeim HA. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Medline abstract, N=80
[Link]; page 342
53 J Neurosurg Anesthesiol. 2001 Apr;13(2):93-8. Walder B. Propofol [correction of propfol] versus methohexital for electroconvulsive therapy: a meta-analysis.
[Link]; page 343
54 Bipolar Disord. 2001 Apr;3(2):95-104. Daly JJ. ECT in bipolar and unipolar depression: differences in speed of response. Medline abstract, N=228
[Link]; page 343
55 BMJ. 2001 Jul 21;323(7305):130. Ferriman A. Levels of neurosis remained static in the 1990s.
[Link]; page 344
56 Psychol Med. 1999 Nov;29(6):1425-34. Fisher PL. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Medline abstract, N=404
[Link]; page 344
57 Depress Anxiety. 2001;14(4):255-62. Randall CL. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Medline abstract, N=9
[Link]; page 344
58 Ballenger JC. Consensus statement on generalised anxiety disorder from the international consensus group on depression and anxiety. Journal of Clinical Psychiatry 2001;62(Suppl. 11):53-58 ; No link available; page 344
59 Arch Gen Psychiatry. 1998 Apr;55(4):317-25. Marks I. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Medline abstract, N=87
[Link]; page 344
60 J Cardiovasc Surg (Torino). 1997 Feb;38(1):69-75. Ashton C Jr. Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. Medline abstract, N=32
[Link]; page 344
61 Br J Psychiatry. 1999 Aug;175:120-6. Baldwin D. Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group.
[Link]; page 346
62 Depress Anxiety. 1999;10(3):89-98. Liebowitz MR. Cognitive-behavioral group therapy versus phenelzine in social phobia: long-term outcome.
[Link]; page 346
63 BMJ. 1995 Jul 15;311(6998):167-70. Ramsay R. Recent advances. Psychiatry.
[Link]; page 346
64 Am J Psychiatry. 2000 Nov;157(11):1782-8. Simeon D. Feeling unreal: a PET study of depersonalization disorder.
[Link]; page 346
65 Camus, Albert--in the Brittanica encyclopaedia
[Link]; page 346
66 South Med J. 2001 Feb;94(2):197-204. Radford B. Pokemon contagion: photosensitive epilepsy or mass psychogenic illness? Medline abstract, n=12,000
[Link]; page 346
67 Am J Psychiatry 157:1890, November 2000 New DSM-IV Diagnosis of Acute Stress Disorder--DAVID SPIEGEL
[Link]; page 347
68 Posttraumatic Stress Disorder DSM-IV Diagnosis & Criteria
[Link]; page 347
69 N Engl J Med. 2002 Jan 10;346(2):108-14. Yehuda R. Post-traumatic stress disorder.
[Link]; page 347
70 Semin Clin Neuropsychiatry. 2001 Apr;6(2):131-45. Villarreal G. Brain imaging in posttraumatic stress disorder.
[Link]; page 347
71 BMJ 2002 324 1523 and A Van Emmerik 2002 Lancet 360 766 [dual ref]; No link available; page 347
72 World Health Organisation 1992: The Classification of Mental and Behavioural disorders. Geneva:WHO
[Link]; page 348
73 J Am Acad Child Adolesc Psychiatry. 2000 Oct;39(10):1284-92. Lewinsohn PM. Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood.
[Link]; page 348
74 Morgan J,Treasure J: Anorexia nervosa diagnosis and treatment
[Link]; page 348
75 Behav Res Ther. 1999 Jan;37(1):1-13. Fairburn CG. A cognitive behavioural theory of anorexia nervosa.
[Link]; page 348
76 J Am Acad Child Adolesc Psychiatry. 2000 Oct;39(10):1284-92. Lewinsohn PM. Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood.
[Link]; page 348
77 Psychol Med. 1995 May;25(3):567-79. Wichstrom L. Social, psychological and physical correlates of eating problems. A study of the general adolescent population in Norway.
[Link]; page 348
78 Gartner AF, Marcus RN, Halmi K, Loranger AW. DSM-III-R personality disorders in patients with eating disorders Am J Psychiatry. 1989 Dec;146(12):1585-91
[Link]; page 348
79 Br J Psychiatry. 1979 Jan;134:71-8. Halmi KA. Pretreatment predictors of outcome in anorexia nervosa.
[Link]; page 348
80 Child Abuse Negl. 1996 Jul;20(7):633-42. Welch SL. Childhood sexual and physical abuse as risk factors for the development of bulimia nervosa: a community-based case control study.
[Link]; page 348
81 Morgan J, Treasure J: Anorexia nervosa diagnosis and treatment.
[Link]; page 348
82 Morgan JF, Reid F, Lacey JH. The SCOFF questionairre: Assessment of anew screening tool for eating disorders. BMJ. 1999 Dec 4;319:1467-8
[Link]; page 348
83 Arch Gen Psychiatry. 1995 Apr;52(4):304-12. Fairburn CG. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Medline abstract, N=99
[Link]; page 348
84 Behav Res Ther. 1999 Jan;37(1):1-13. Fairburn CG. A cognitive behavioural theory of anorexia nervosa.
[Link]; page 348
85 Eating disorders, core interventions in the treatment and management of anorexia nervosa,bulimia nervosa and related eating disorders.
[Link]; page 349
86 Morgan J, Treasure J: Anorexia nervosa diagnosis and treatment.
[Link]; page 349
87 Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002 Aug 159(8)1284-93
[Link]; page 349
88 World Health Organisation1992: The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO
[Link]; page 349
89 Hall A, Hey PJ: Eating disorder referals from apopulation region 1977-1986. Psychol Med 1991 Aug 21(3), 697-701
[Link]; page 349
90 Mumford, D.B.; Whitehouse, A.M. - Increased prevalence of bulimia nervosa among Asian schoolgirls. B.M.J., 297: 718, 1988
[Link]; page 349
91 Cooper PJ, Steere JA: Comparison of two psychological treatments for bulimia nervosa: Implications for models of maintenance. Behaviour Research and Therapy,1995 33(8):875-885
[Link]; page 349
92 Bulik CM, Sullivan PF, Wade T, Kendler KS. Twin studies of eating disorders: A review. International Journal of eating disorders, 2000, 28(2):139-47
[Link]; page 349
93 Primary care protocols for common mental illnesses. Protocol III: Eating Disorders (18+years) identification and referral. Royal College of Psychiatrists.
[Link]; page 349
94 Antidepressants versus psychological treatments and their combination for bulimia nervosa (Cochrane Review)
[Link]; page 349
95 Hay PJ, Bacaltchuck J. Psychotherapy for bulimia nervosa and binging (Cochrane Review). The Cochrane Library, Issue 1, 2004. Chichester, UK. John Wiley & Sons Ltd.
[Link]; page 349
96 Hsu LK. Outcome of bulimia nervosa. KD Brownell and CG Fairburn (Eds), Eating disorders and obesity. ISBN 0898628504 (p238-246)
[Link]; page 349
97 Int J Geriatr Psychiatry. 2001 Apr;16(4):349-55. Galanakis P. Acute confusional state in the elderly following hip surgery: incidence, risk factors and complications.
[Link]; page 350
98 BMJ. 2001 Jan 20;322(7279):144-9. Meagher DJ. Delirium: optimising management.
[Link]; page 350
99 Can J Neurol Sci. 2001 Feb;28 Suppl 1:S28-41. Chertkow H. Assessment of suspected dementia.
[Link]; page 350
100 Lancet. 2000 Nov 11;356(9242):1627-31. Jick H. Statins and the risk of dementia. Medline abstract, n=1364
[Link]; page 350
101 Surg Neurol. 2000 Mar;53(3):201-7. Boon AJ. The Dutch normal-pressure hydrocephalus study. How to select patients for shunting? An analysis of four diagnostic criteria.
[Link]; page 351
102 Ital J Neurol Sci. 1998 Apr;19(2):86-9. Logullo F. Reversible combined cognitive impairment and severe polyneuropathy resulting from primary hyperparathyroidism.
[Link]; page 351
103 Ned Tijdschr Geneeskd. 1998 Aug 15;142(33):1880-2 (Dutch). Pasmans SG. [Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan): a disease still extant in the Netherlands]
[Link]; page 351
104 J Clin Psychiatry. 1987 Sep;48(9):368-70. Cooper AJ. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia.
[Link]; page 351
105 Lancet 2002 Magnetic-resonance imaging to assess Alzheimer's disease. Ingmar Skoog
[Link]; page 352
106 Neuropsychobiology. 2002;45(1):19-26. Le Bars PL. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
[Link]; page 352
107 JAMA. 2002 Feb 13;287(6):742-8. Wilson RS. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. Medline abstract, n=801
[Link]; page 352
108 Healthy aging and dementia: findings from the Nun Study. Author: Snowdon DA, Nun Study. Journal: Ann Intern Med; 2003 Sep 2 ; 139(5 Pt 2):450-4. PubMed ID: 12965975
[Link]; page 352
109 Eur J Neurol. 2001 Sep;8(5):435-40 The validity of Hodkinson's Abbreviated Mental Test for dementia screening in Guipuzcoa, Spain. Sarasqueta C
[Link]; page 353
110 Neurological examination
[Link]; page 353
111 Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators. Author: Zuccalˆ G, Onder G, Pedone C, Cocchi A, Carosella L, Cattel C, Carbonin PU, Bernabei R. Journal: J Neurol Neurosurg Psychiatry; 2001 Jan ; 70(1):109. PubMed ID: 11118258
[Link]; page 353
112 Am J Psychiatry. 1998 Nov;155(11):1529-35. Mackinnon A. Combining cognitive testing and informant report to increase accuracy in screening for dementia.
[Link]; page 353
113 Sample chart to fill in for frontal lobe function
[Link]; page 353
114 Angst J, Marneros A. Bipolarity from ancient to modern times:conception, birth and rebirth. J Affect Disord 2001;67:3-19
[Link]; page 354
115 Mayo Clin Proc. 1988 Sep;63(9):906-12. Mayo Clin Proc. 1989 Jan;64(1):129 Organic causes of mania. Larson EW
[Link]; page 354
116 Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Author: Sproule B. Journal: Clin Pharmacokinet; 2002 ; 41(9):639-60. PubMed ID: 12126457
[Link]; page 354
117 J Clin Psychopharmacol. 2000 Apr;20(2):195-203. Muller-Oerlinghausen B. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
[Link]; page 355
118 Tohen M Arch Gen Psy quoted in Drug Ther Bul 2005 33 [no link]; page 355
119 Ichim L et al. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000;12:5-10
[Link]; page 355
120 Kramlinger et al. ADDing lithium carbonate to carbemazepine: antimanic efficacy in treatment resistant mania. Acta Psychiatr Scand 1989;79:378-385
[Link]; page 355
121 Miller DS et al. Comparitive efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania. J Clin Psychiatry 2001;62:975-980
[Link]; page 355
122 Tohen M et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62-69
[Link]; page 355
123 Postgrad Med. 2000 Apr;Spec No:1-104. Sachs GS. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.
[Link]; page 355
124 J Clin Psychiatry. 2000;61 Suppl 9:57-67. Compton MT. The treatment of bipolar depression.
[Link]; page 355
125 Mukherjee S et al. Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 1994;151:169-176
[Link]; page 355
126 Grisaru N et al. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 1998;155:1608-1610
[Link]; page 355
127 Perry A et al. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999;318:149-153
[Link]; page 355
128 Kraeplin E 1919 Dementia praecox and paraphrenia (translated by RM Barclay). Livingstone: Edinburgh
[Link]; page 356
129 Wiersma D et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998;24:75-85
[Link]; page 356
130 Mueser KT, McGurk SR. Schizophrenia. Lancet 2004;363:2063-72
[Link]; page 356
131 Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin I and susceptibilityto schizophrenia. Am J Hum Genet 2002;71:877-92
[Link]; page 356
132 Straub RE, Jiang Y, Maclean CJ, et al. Genetic Variation in the 6p22. Gene DTNBPI, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002;71:337-48
[Link]; page 356
133 Murray R. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry. Oct 2004 Vol 8 Issue 8:20-26
[Link]; page 356
134 Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction. Journal: Biol Psychiatry; 2005 May 15 ; 57(10):1117-1127. PubMed ID: 15866551
[Link]; page 356
135 andreasson S, Allebeck P, Engstrom A, et al. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483-6
[Link]; page 356
136 Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis:longitudinal prospective study. BMJ 2002;325:1212-3
[Link]; page 356
137 Jones et al. Child development risk factors for adult schizophrenia in the British 1946 cohort.Lancet. 1994, 344:1398-1402
[Link]; page 356
138 Jones et al. Schizophrenia as a long-term outcome of pregnancy, delivery and perinatal complications: a 28-year follow-up of the 1966 north Finland general population cohort. Am J Psych. 1998, 155(3):355-64
[Link]; page 356
139 Puri BK, Hall AD. Revision notes in psychiatry. Arnold (2nd edition) pg377-8. ISBN 0340761318
[Link]; page 356
140 Murray RM, O'Callaghan E, Castle DJ, Lewis SW. 1992: A neurodevelopmental approach to the classification to schizophrenia. Schizophrenia Bulletin 18:319-332
[Link]; page 356
141 Murray RM. New ways of thinking about and treating psychosis. Keynote lecture. Progress in Neurology and Psychiatry. Oct 2004 Vol 8 Issue 8:20-26
[Link]; page 356
142 Murray RM. New ways of thinking about and treating psychosis. Keynote lecture, Latest advances in Psychiatry Symposium. Progress in Neurology and Psychiatry. 2004 Vol 8 Issue 8:20-26
[Link]; page 357
143 Shergill SS, Bullmore ET, Brammer MJ, et al (2001) A functional MRI study of auditory verbal imagery. Psychol Med, 31:241-253
[Link]; page 357
144 Encephale. 1995 Mar-Apr;21(2):93-8 (French). Huguelet P. [Four year follow-up of social adjustment of a cohort of schizophrenic patients]
[Link]; page 358
145 Maudsley prescribing gudelines 2003. ISBN 1-4184-176-5
[Link]; page 360
146 Bagnall A-M et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health technol Assess 2003;7(13)
[Link]; page 360
147 Davis JM et al. A meta-analysis of the efficacy of second generation antipsychotics. Arch Gen Psych 2003;60:553-64
[Link]; page 360
148 Leucht S et al. Relapse prevention in schizophrenia with new-generation antipsychotic: a systematic review and exploratory meta-analysis of randomized controlled trials. Am J Psych 2003;160:1209-22
[Link]; page 360
149 Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;62:1649-71
[Link]; page 360
150 Leucht S et al. New generation antipsychotics versus low-potency conventional antipsychotics:a systematic review and meta-analysis. Lancet 2003;361:1581-9
[Link]; page 360
151 Arvanitis LA et al. Multiple fixed doses of quetiapine in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-46
[Link]; page 360
152 Volavka J et al. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 2004; 65:57-61
[Link]; page 360
153 Risperidone-associated ejaculatory and urinary dysfunction in male adolescents. Author: Holtmann M, Gerstner S, Schmidt MH. Journal: J Child Adolesc Psychopharmacol; 2003 Spring ; 13(1):107-9. PubMed ID: 12804132
[Link]; page 361
154 Risperidone-Induced Ejaculatory Disturbances. Michael T
[Link]; page 361
155 A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. Author: Rosenberg KP, Bleiberg KL, Koscis J, Gross C. Journal: J Sex Marital Ther; 2003 Jul-Aug ; 29(4):289-96. PubMed ID: 14504017
[Link]; page 361
156 Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Author: Keller R, Mongini F. Journal: Neurol Sci; 2002 Dec ; 23(5):233-5. PubMed ID: 12522680
[Link]; page 361
157 Taylor DM, McAskill R. Atypical antipsychotics and weight gain- a systematic review. Acta Psychiatr Scand 2000; 101:416-32
[Link]; page 361
158 American diabetes Association et al, consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes care 2004; 27:596-601
[Link]; page 361
159 Duff G. Atypical antipsychotic drugs and stroke. CEM/CMO/2004/1. Committee on Safety of Medicines, 2004
[Link]; page 361
160 Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (NICE guideline) December 2002
[Link]; page 361
161 Pharoah FM, Rathbone J, Mari JJ, Streiner D. Family intervention for schizophrenia (Cochrane Review). The Cochrane Library, Issue 4, 2004, Chichester UK. John Wiley & Sons Ltd.
[Link]; page 361
162 Jones C, CormacI, Silveira da Mota Neto JL, Campbell C. Cognitive behaviour therapy for schizophrenia (cochrane review). The Cochrane Library, Issue 4, 2004. Chichester, Uk. John Wiley & Sons Ltd.
[Link]; page 361
163 Office of national statistics. UK government.
[Link]; page 362
164 The National Alcohol Harm Reduction Strategy. UK government.
[Link]; page 362
165 Br J Psychiatry. 1998 Oct;173:345-50. Kendler KS. Cocaine use, abuse and dependence in a population-based sample of female twins.
[Link]; page 362
166 World Health Organisation.ICD-10 Internationall Classification of Mental and Behavioural Disorders.
[Link]; page 362
167 Addiction. 2000 Feb;95(2):219-28. Petrakis IL. Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts.
[Link]; page 362
168 Am J Addict. 1999 Fall;8(4):337-48. Strang J. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
[Link]; page 362
169 JAMA. 1998 Jul 8;280(2):166-71. Bradley KA. Alcohol screening questionnaires in women: a critical review.
[Link]; page 363
170 J Stud Alcohol. 1999 Sep;60(5):705-11. Cherpitel CJ. Screening for alcohol problems in the U.S. general population: a comparison of the CAGE and TWEAK by gender, ethnicity, and services utilization.
[Link]; page 363
171 JAMA. 1997 Jul 9;278(2):144-51. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.
[Link]; page 363
172 Addiction. 2001 Nov;96(11):1565-73. Morris PL. Naltrexone for alcohol dependence: a randomized controlled trial. Medline abstract, N=111
[Link]; page 363
173 Eur Addict Res. 2000 Jun;6(2):71-8. Annemans L. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients.
[Link]; page 363
174 J Consult Clin Psychol. 1998 Jun;66(3):541-8. Smith JE. The community reinforcement approach with homeless alcohol-dependent individuals.
[Link]; page 363
175 Gelder M. Oxford Textbook of Psychiatry. 2003. ISBN-0-19-852810-8.
[Link]; page 364
176 Disabil Rehabil. 1999 Sep;21(9):409-19. Messent PR. Primary and secondary barriers to physically active healthy lifestyles for adults with learning disabilities.
[Link]; page 364
177 Mencap
[Link]; page 364
178 J Personal Disord. 2001 Apr;15(2):103-9. Gunderson JG. Differentiating narcissistic and antisocial personality disorders.
[Link]; page 366
179 J Consult Clin Psychol. 1999 Feb;67(1):82-94. Weiss B. The effectiveness of traditional child psychotherapy. Medline abstract, N=160
[Link]; page 366
180 Am J Psychiatry. 1999 Sep;156(9):1312-21. Perry JC. Effectiveness of psychotherapy for personality disorders.
[Link]; page 366
181 J Personal Disord. 2000 Fall;14(3):282-90. Brieger P. The relationship between five-factor personality measurements and ICD-10 personality disorder dimensions: results from a sample of 229 subjects.
[Link]; page 366
182 Advances in Psychiatric Treatment (2003) 9: 349-358 Dangerous severe personality disorder. Adrian Feeney
[Link]; page 366
183 Advances in Psychiatric Treatment (2003) 9: 349-358 Dangerous severe personality disorder. Adrian Feeney
[Link]; page 367
184 Antidepressant discontinuation syndrome:update on serotonin reuptake inhibitors. Journal of Clinical Psychiatry 1997;58(Suppl.7):3-40 ; no link available; page 368
185 Lejoyeux M et al. Antidepressant withdrawal syndrome:recognition, prevention and management. CNS Drugs1996;5:278-292; No link available; page 368
186 Sternbach H. The serotonin syndrome. American Journal of Psychiatry 1999;148:705-713; No link available; page 369
187 The Maudsely prescribing guidelines 2003 ISBN 1-4184-176-5
[Link]; page 369
188 Williams C. Garland A. A cognitive behavioural therapy asessment model for use in everyday clinical practice. Adv Psychiatr Treat. May 2002. 8:172-179
[Link]; page 374
189 Br J Gen Pract. 2000 Dec;50(461):963-8. Sharp DM. Reducing therapist contact in cognitive behaviour therapy for panic disorder and agoraphobia in primary care: global measures of outcome in a randomised controlled trial. Medline abstract, N=104
[Link]; page 375
190 BMJ 2002;324:947 Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial--Michael King
[Link]; page 375
191 J Psychiatr Ment Health Nurs. 2004 Oct;11(5):508-13. Computerized cognitive-behaviour therapy for anxiety and depression: a practical solution to the shortage of trained therapists--van den Berg S
[Link]; page 375
192 Cochrane Database Syst Rev. 2000;(2):CD001292. Lancaster T. Individual behavioural counselling for smoking cessation.
[Link]; page 376
193 Cancer. 2000 Sep 1;89(5):1026-36. Fukui S. A psychosocial group intervention for Japanese women with primary breast carcinoma.
[Link]; page 376
194 Int J Psychoanal. 2000 Dec;81 Pt 6:1139-54. Joyce A. Insight and the nature of therapeutic action in the psychoanalysis of 4- and 5-year-old children.
[Link]; page 377
195 NICE 2004 & GP 22 April 2005 page 33
[Link]; page 377
196 Cochrane Database Syst Rev. 2000;(2):CD001087. Joy CB. Crisis intervention for people with severe mental illnesses.
[Link]; page 378
197 Johnsons; 2003 BMJ, 331, 599-602
[Link]; page 379
198 Cognitive behaviour therapy for schizophrenia. Jones C, Cochrane Database Syst Rev. 2000;(2):CD000524">[Link]; page 380
199 BMJ. 2000 Dec 2;321(7273):1389-92. Bower P. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. Medline abstract, N=197
[Link]; page 381
200 BMJ. 2000 Dec 2;321(7273):1383-8. Ward E. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: clinical effectiveness.
[Link]; page 381
